Every year, half a million people suffer spinal cord injury

These patients are normally aged between 25 and 45 years old, and end unable to work, with estimated healthcare costs and value loss of 3M€

We can change that with NeoSpinnae

the novel implantable biomaterial that promotes sensory and motor recovery following spinal cord injury.

The beneficiaries are spinal cord injury patients

the business model is based on supplying the device to healthcare providers, such as hospitals, clinics, and national health services.

Made possible by:

Stay up to date

Things are moving fast and we would like to keep you up to date with our progress.  Sign up to stay in the loop.

Thank you for your message. It has been sent.
There was an error trying to send your message. Please try again later.

By submitting my data I agree to be contacted